TY  - JOUR
PY  - 2020//
TI  - United States drug courts and opioid agonist therapy: missing the target of overdose reduction
JO  - Forensic science international: mind and law
A1  - Csete, Joanne
SP  - e100024
EP  - e100024
VL  - 1
IS  - 
N2  - Highlights    • Agonist therapy for opioid use disorder (OUD) is often inaccessible in the US at a time of high overdose mortality.   • OUD therapy could be offered by drug treatment courts as an alternative to criminal prosecution for some drug offenses.   • Many drug courts, however, reject gold-standard agonist therapies, seeing them as "another form of addiction".   • Drug courts often prefer to offer extended-release naltrexone, but it is costly and requires pre-treatment abstinence.   • Drug courts have had limited success in improving access to OUD treatment at a time of high overdose mortality.<p />  <p>Language: en</p>
LA  - en
SN  - 2666-3538
UR  - http://dx.doi.org/10.1016/j.fsiml.2020.100024
ID  - ref1
ER  -